Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,475 | 47 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,307 | 14 | $0 (2024) |
| GlaxoSmithKline, LLC. | $692.34 | 6 | $0 (2024) |
| ABBVIE INC. | $253.64 | 9 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $162.52 | 2 | $0 (2022) |
| Corcept Therapeutics | $134.35 | 2 | $0 (2024) |
| DEXCOM, INC. | $126.47 | 6 | $0 (2021) |
| IDORSIA PHARMACEUTICALS US INC | $124.98 | 1 | $0 (2023) |
| Novo Nordisk Inc | $123.95 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $122.00 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $121.47 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $868.96 | 9 | GlaxoSmithKline, LLC. ($241.76) |
| 2023 | $1,366 | 14 | AstraZeneca Pharmaceuticals LP ($542.25) |
| 2022 | $560.71 | 7 | AstraZeneca Pharmaceuticals LP ($190.41) |
| 2021 | $679.39 | 17 | AstraZeneca Pharmaceuticals LP ($336.81) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Endocrinology | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $130.65 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $115.80 | General |
| Category: Endocrinology | ||||||
| 08/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $121.88 | General |
| Category: IMMUNOLOGY | ||||||
| 05/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $121.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $119.88 | General |
| Category: RESPIRATORY | ||||||
| 02/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $113.41 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: NEUROSCIENCE | ||||||
| 01/17/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $106.45 | General |
| Category: Respiratory | ||||||
| 12/06/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $117.74 | General |
| Category: Oncology | ||||||
| 11/29/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $122.00 | General |
| Category: DIABETES | ||||||
| 11/06/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Respiratory | ||||||
| 10/10/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $118.09 | General |
| Category: Respiratory | ||||||
| 09/27/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $119.68 | General |
| Category: RESPIRATORY | ||||||
| 08/23/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $120.06 | General |
| Category: Respiratory | ||||||
| 07/27/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $117.37 | General |
| 07/25/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Obesity | ||||||
| 06/14/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $118.47 | General |
| Category: Respiratory | ||||||
| 05/16/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $105.53 | General |
| Category: Respiratory | ||||||
| 04/26/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $101.67 | General |
| Category: Obesity | ||||||
| 04/05/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: INSOMNIA | ||||||
| 03/08/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $97.72 | General |
| 02/01/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $66.98 | General |
| Category: Respiratory | ||||||
| 11/07/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Respiratory | ||||||
| 10/04/2022 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $115.81 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 197 | 226 | $60,306 | $12,277 |
| 2022 | 21 | 1,041 | 1,566 | $336,894 | $86,043 |
| 2021 | 16 | 892 | 1,218 | $247,841 | $65,763 |
| 2020 | 11 | 691 | 961 | $197,754 | $45,223 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 121 | $34,122 | $7,132 | 20.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 17 | $6,800 | $1,866 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 34 | $6,800 | $1,499 | 22.0% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 16 | 16 | $5,536 | $1,222 | 22.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 14 | 15 | $6,174 | $423.80 | 6.9% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 17 | 23 | $874.00 | $136.03 | 15.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 363 | 698 | $188,868 | $45,488 | 24.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 62 | 68 | $25,828 | $7,758 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 125 | 150 | $28,669 | $7,063 | 24.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 18 | 18 | $9,322 | $5,028 | 53.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 61 | 61 | $3,447 | $3,378 | 98.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 26 | 26 | $13,468 | $2,847 | 21.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 87 | 87 | $2,770 | $2,439 | 88.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 43 | 61 | $24,356 | $2,326 | 9.5% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 12 | 12 | $2,160 | $1,600 | 74.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $13,738 | $1,599 | 11.6% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 12 | 12 | $5,827 | $1,365 | 23.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 33 | 33 | $1,000 | $934.17 | 93.4% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 13 | 13 | $4,348 | $930.61 | 21.4% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 20 | 20 | $1,200 | $739.00 | 61.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 26 | 26 | $695.00 | $544.42 | 78.3% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 12 | 13 | $2,773 | $494.92 | 17.8% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 12 | 12 | $720.00 | $446.74 | 62.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 13 | $1,522 | $391.77 | 25.7% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 28 | 42 | $1,596 | $320.41 | 20.1% |
About Timothy Johnson, PA
Timothy Johnson, PA is a Physician Assistant healthcare provider based in Avon, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/26/2010. The National Provider Identifier (NPI) number assigned to this provider is 1033425145.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Timothy Johnson, PA has received a total of $3,475 in payments from pharmaceutical and medical device companies, with $868.96 received in 2024. These payments were reported across 47 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($3,475).
As a Medicare-enrolled provider, Johnson has provided services to 2,821 Medicare beneficiaries, totaling 3,971 services with total Medicare billing of $209,307. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Avon, IN
- Active Since 08/26/2010
- Last Updated 08/26/2010
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1033425145
Products in Payments
- FASENRA (Biological) $426.94
- TEZSPIRE (Biological) $415.46
- BREZTRI (Drug) $333.52
- AREXVY (Drug) $239.56
- UBRELVY (Drug) $223.38
- Kerendia (Drug) $162.52
- Korlym (Drug) $134.35
- AIRSUPRA (Drug) $130.65
- DEXCOM G6 TRANSMITTER (Device) $126.47
- QUVIVIQ (Drug) $124.98
- Wegovy (Drug) $123.95
- JARDIANCE (Drug) $122.00
- NUCALA (Biological) $121.88
- LEQVIO (Drug) $121.47
- Cologuard Collection Kit (Device) $117.74
- DUPIXENT (Biological) $113.41
- NURTEC ODT (Drug) $75.31
- QULIPTA (Drug) $30.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Avon
Lisa Sheehan, Pa-C, PA-C
Physician Assistant — Payments: $7,134
Justyna Pachowska, Pa-C, PA-C
Physician Assistant — Payments: $6,148
Emily Kriech, Pa-C, PA-C
Physician Assistant — Payments: $5,257
Anja Panetta, Pa, PA
Physician Assistant — Payments: $3,981
Megan Allison, Pa-C, PA-C
Physician Assistant — Payments: $2,259
Laura Worley, Pa-C, PA-C
Physician Assistant — Payments: $1,843